The role of phosphorylation in atrial fibrillation: a focus on mass spectrometry approaches. Issue 5 (21st March 2021)

• Record Type: Journal Article
• Authors: Safabakhsh, Sina; Panwar, Pankaj; Barichello, Scott; Sangha, Sarabjit S; Hanson, Paul J; Petegem, Filip Van; Laksman, Zachary
• Is Part Of: Cardiovascular research. Volume 118:Issue 5(2022)
• Page Start: 1205
• Page End: 1217
• Publication Date: 2021-03-21
• Subjects: Electrophysiology -- Arrhythmia -- Phosphorylation -- Pathophysiology -- Biochemistry; Cardiovascular system -- Diseases -- Periodicals; Cardiovascular system -- Periodicals; 616.1
• DOI: 10.1093/cvr/cvab095
• Languages: English
• ISSNs: 0008-6363

Abstract

Abstract: Atrial fibrillation (AF) is the most common arrhythmia worldwide. It is associated with significant increases in morbidity in the form of stroke and heart failure, and a doubling in all-cause mortality. The pathophysiology of AF is incompletely understood, and this has contributed to a lack of effective treatments and disease-modifying therapies. An important cellular process that may explain how risk factors give rise to AF includes post-translational modification of proteins. As the most commonly occurring post-translational modification, protein phosphorylation is especially relevant. Although many methods exist for studying protein phosphorylation, a common and highly resolute technique is mass spectrometry (MS). This review will discuss recent evidence surrounding the role of protein phosphorylation in the pathogenesis of AF. MS-based technology to study phosphorylation and uses of MS in other areas of medicine such as oncology will also be presented. Based on these data, future goals and experiments will be outlined that utilize MS technology to better understand the role of phosphorylation in AF and elucidate its role in AF pathophysiology. This may ultimately allow for the development of more effective AF therapies.